» Articles » PMID: 36683855

Cell Type-specific Histone Acetylation Profiling of Alzheimer's Disease Subjects and Integration with Genetics

Overview
Specialty Molecular Biology
Date 2023 Jan 23
PMID 36683855
Authors
Affiliations
Soon will be listed here.
Abstract

We profile genome-wide histone 3 lysine 27 acetylation (H3K27ac) of 3 major brain cell types from hippocampus and dorsolateral prefrontal cortex (dlPFC) of subjects with and without Alzheimer's Disease (AD). We confirm that single nucleotide polymorphisms (SNPs) associated with late onset AD (LOAD) show a strong tendency to reside in microglia-specific gene regulatory elements. Despite this significant colocalization, we find that microglia harbor more acetylation changes associated with age than with amyloid-β (Aβ) load. In contrast, we detect that an oligodendrocyte-enriched glial (OEG) population contains the majority of differentially acetylated peaks associated with Aβ load. These differential peaks reside near both early onset risk genes () and late onset AD risk loci (including ), Aβ processing genes (), as well as genes involved in myelinating and oligodendrocyte development processes. Interestingly, a number of LOAD risk loci associated with differentially acetylated risk genes contain H3K27ac peaks that are specifically enriched in OEG. These findings implicate oligodendrocyte gene regulation as a potential mechanism by which early onset and late onset risk genes mediate their effects, and highlight the deregulation of myelinating processes in AD. More broadly, our dataset serves as a resource for the study of functional effects of genetic variants and cell type specific gene regulation in AD.

Citing Articles

Multi Layered Omics Approaches Reveal Glia Specific Alterations in Alzheimer's Disease: A Systematic Review and Future Prospects.

Is O, Min Y, Wang X, Oatman S, Abraham Daniel A, Ertekin-Taner N Glia. 2024; 73(3):539-573.

PMID: 39652363 PMC: 11784841. DOI: 10.1002/glia.24652.


Transcriptional Patterns in Stages of Alzheimer's Disease Are Cell-Type-Specific and Partially Converge with the Effects of Alcohol Use Disorder in Humans.

Joshi A, Giorgi F, Sanna P eNeuro. 2024; 11(10).

PMID: 39299805 PMC: 11485264. DOI: 10.1523/ENEURO.0118-24.2024.


Regression convolutional neural network models implicate peripheral immune regulatory variants in the predisposition to Alzheimer's disease.

Ramamurthy E, Agarwal S, Toong N, Sestili H, Kaplow I, Chen Z PLoS Comput Biol. 2024; 20(8):e1012356.

PMID: 39186798 PMC: 11389932. DOI: 10.1371/journal.pcbi.1012356.


Proteins linking APOE ɛ4 with Alzheimer's disease.

Oveisgharan S, Yu L, de Paiva Lopes K, Tasaki S, Wang Y, Menon V Alzheimers Dement. 2024; 20(7):4499-4511.

PMID: 38856164 PMC: 11247662. DOI: 10.1002/alz.13867.


KAT8 beyond Acetylation: A Survey of Its Epigenetic Regulation, Genetic Variability, and Implications for Human Health.

Yoo L, Mendoza D, Richard A, Stephens J Genes (Basel). 2024; 15(5).

PMID: 38790268 PMC: 11121512. DOI: 10.3390/genes15050639.


References
1.
Bennett D, Wilson R, Arvanitakis Z, Boyle P, de Toledo-Morrell L, Schneider J . Selected findings from the Religious Orders Study and Rush Memory and Aging Project. J Alzheimers Dis. 2012; 33 Suppl 1:S397-403. PMC: 3434299. DOI: 10.3233/JAD-2012-129007. View

2.
Lee J, Xu J, Lee J, Ku G, Han X, Yang D . Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway. J Cell Biol. 2004; 164(1):123-31. PMC: 2171973. DOI: 10.1083/jcb.200307017. View

3.
Szklarczyk D, Gable A, Nastou K, Lyon D, Kirsch R, Pyysalo S . The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2020; 49(D1):D605-D612. PMC: 7779004. DOI: 10.1093/nar/gkaa1074. View

4.
Saito R, Smoot M, Ono K, Ruscheinski J, Wang P, Lotia S . A travel guide to Cytoscape plugins. Nat Methods. 2012; 9(11):1069-76. PMC: 3649846. DOI: 10.1038/nmeth.2212. View

5.
Naj A, Jun G, Beecham G, Wang L, Vardarajan B, Buros J . Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet. 2011; 43(5):436-41. PMC: 3090745. DOI: 10.1038/ng.801. View